Bcl‐xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms

Jessica Petiti(University of Turin), Daniela Cilloni(University of Turin)
Journal of Cellular and Molecular Medicine
August 13, 2020
Cited by 33


Related Papers